BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1715927)

  • 1. Pharmacological studies on lappaconitine: antinociception and inhibition of the spinal action of substance P and somatostatin.
    Ono M; Satoh T
    Jpn J Pharmacol; 1991 Apr; 55(4):523-30. PubMed ID: 1715927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord.
    Ohkubo T; Shibata M; Takahashi H; Inoki R
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1261-8. PubMed ID: 1690801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies of lappaconitine. Analgesia produced by intracerebroventricular, intracisternal and intrathecal injections.
    Ono M; Satoh T
    J Pharmacobiodyn; 1990 Jun; 13(6):374-7. PubMed ID: 2231269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord.
    Sakurada T; Wako K; Sakurada C; Manome Y; Tan-no K; Sakurada S; Kisara K
    Brain Res; 1996 Jun; 724(2):213-21. PubMed ID: 8828571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural characterization of substance P-induced nociceptive response in mice.
    Takahasi K; Sakurada T; Sakurada S; Kuwahara H; Yonezawa A; Ando R; Kisara K
    Neuropharmacology; 1987 Sep; 26(9):1289-93. PubMed ID: 2444899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord.
    Sakurada T; Katsumata K; Tan-No K; Sakurada S; Kisara K
    Neuropharmacology; 1992 Dec; 31(12):1279-85. PubMed ID: 1281912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies of lappaconitine: supraspinal-spinal interaction in antinociception.
    Ono M; Satoh T
    Arch Int Pharmacodyn Ther; 1991; 309():32-41. PubMed ID: 1888228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters.
    DeLander GE; Wahl JJ
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1090-5. PubMed ID: 2481030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural responses induced by intrathecal injection of 5-hydroxytryptamine in mice are inhibited by a substance P antagonist, D-Pro2, D-Trp7,9-substance P.
    Fasmer OB; Post C
    Neuropharmacology; 1983 Dec; 22(12A):1397-400. PubMed ID: 6198594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors.
    Sakurada T; Katsuyama S; Sakurada S; Inoue M; Tan-No K; Kisara K; Sakurada C; Ueda H; Sasaki J
    Br J Pharmacol; 1999 Aug; 127(7):1712-8. PubMed ID: 10455330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
    Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mexiletine on formalin-induced nociceptive responses in mice.
    Kamei J; Hitosugi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):153-62. PubMed ID: 7686682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments.
    Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T
    Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat.
    Björkman R
    Acta Anaesthesiol Scand Suppl; 1995; 103():1-44. PubMed ID: 7725891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies on lappaconitine: possible interaction with endogenous noradrenergic and serotonergic pathways to induce antinociception.
    Ono M; Satoh T
    Jpn J Pharmacol; 1992 Mar; 58(3):251-7. PubMed ID: 1513074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of spinal cord activation before neurectomy in the development of autotomy.
    Asada H; Yamaguchi Y; Tsunoda S; Fukuda Y
    Pain; 1996 Jan; 64(1):161-167. PubMed ID: 8867259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: a behavioural and microdialysis study in rats.
    Watanabe C; Okuda K; Sakurada C; Ando R; Sakurada T; Sakurada S
    Brain Res; 2003 Nov; 990(1-2):77-86. PubMed ID: 14568332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal ERK activation via NO-cGMP pathway contributes to nociceptive behavior induced by morphine-3-glucuronide.
    Komatsu T; Sakurada S; Kohno K; Shiohira H; Katsuyama S; Sakurada C; Tsuzuki M; Sakurada T
    Biochem Pharmacol; 2009 Oct; 78(8):1026-34. PubMed ID: 19589334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice.
    Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T
    Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenosides induce differential antinociception and inhibit substance P induced-nociceptive response in mice.
    Yoon SR; Nah JJ; Shin YH; Kim SK; Nam KY; Choi HS; Nah SY
    Life Sci; 1998; 62(21):PL 319-25. PubMed ID: 9619848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.